Evidence map›Paper›PMID 30889575›Full record

ArticleJournal of innate immunity2019

Streptolysin O Induces the Ubiquitination and Degradation of Pro-IL-1β.

Dóra Hancz, Elsa Westerlund, Christine Valfridsson, Getachew Melkamu Aemero, Benedicte Bastiat-Sempe, Pontus Orning, Egil Lien, Michael R Wessels, Jenny J Persson

Open access · goldAbstract read
In one paragraph

Article in Journal of innate immunity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Interplay between group AMicrobiology and molecular biology reviews : MMBR · 2024
    Review
  4. Review
  5. Review
  6. AmBio · 2021
    Article
  7. Review
  8. Playing With Fire: Proinflammatory Virulence Mechanisms of Group AFrontiers in cellular and infection microbiology · 2021
    Review
  9. Review
  10. Article
  11. The Road Not Taken: Commensal or Virulent Pathogen.Journal of innate immunity · 2020
    Article
  12. Tackling the Pros and Cons of Inflammation.Journal of innate immunity · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Dóra HanczImmunology Section, Department of Experimental Medical Sciences, Lund University, Lund, Sweden.
Elsa WesterlundImmunology Section, Department of Experimental Medical Sciences, Lund University, Lund, Sweden.
Christine ValfridssonImmunology Section, Department of Experimental Medical Sciences, Lund University, Lund, Sweden.
Getachew Melkamu AemeroImmunology Section, Department of Experimental Medical Sciences, Lund University, Lund, Sweden.
Benedicte Bastiat-SempeDivision of Infectious Diseases, Boston Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
Pontus OrningProgram in Innate Immunity, Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Egil LienProgram in Innate Immunity, Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Michael R WesselsDivision of Infectious Diseases, Boston Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
Jenny J PerssonImmunology Section, Department of Experimental Medical Sciences, Lund University, Lund, Sweden, jenny_j.persson@med.lu.se.
Lund University · SEBoston Children's Hospital · USNorwegian University of Science and Technology · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Group A Streptococcus (GAS) is a common and versatile human pathogen causing a variety of diseases. One of the many virulence factors of GAS is the secreted pore-forming cytotoxin streptolysin O (SLO), which has been ascribed multiple properties, including inflammasome activation leading to release of the potent inflammatory cytokine IL-1β from infected macrophages. IL-1β is synthesized as an inactive pro-form, which is activated intracellularly through proteolytic cleavage. Here, we use a macrophage infection model to show that SLO specifically induces ubiquitination and degradation of pro-IL-1β. Ubiquitination was dependent on SLO being released from the infecting bacterium, and pore formation by SLO was required but not sufficient for the induction of ubiquitination. Our data provide evidence for a novel SLO-mediated mechanism of immune regulation, emphasizing the importance of this pore-forming toxin in bacterial virulence and pathogenesis.

Indexed as

AnimalsBacterial ProteinsCells, CulturedHumansInflammasomesInterleukin-1betaMacrophagesMiceMice, KnockoutProteolysisStreptococcal InfectionsStreptococcus pyogenesStreptolysinsUbiquitinationVirulence FactorsBacterial ProteinsInflammasomesInterleukin-1betastreptolysin OStreptolysinsVirulence FactorsGroup A StreptococcusStreptolysin OUbiquitin, IL-1β

Identifiers

PMID30889575
PMCPMC6758947
OpenAlexW2924289374

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.